Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M 3-mediated indirect suppression through endocannabinoid signalling

European Journal of Neuroscience

Volumn 19, Issue 10, 2004, Pages 2682-2692

  Fukudome, Yuko ^a   Ohno Shosaku, Takako ^a   Matsui, Minoru ^b   Omori, Yuko ^c   Fukaya, Masahiro ^c   Tsubokawa, Hiroshi ^d   Taketo, Makoto M ^e   Watanabe, Masahiko ^c   Manabe, Toshiya ^b   Kano, Masanobu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Inhibitory transmission; Mouse; Rat; Synaptic modulation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; GALLAMINE; ISOPROTEIN; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR; OXOTREMORINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BRAIN NERVE CELL; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL CULTURE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECORDING; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; CALCIUM CHANNEL BLOCKERS; CARRIER PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOCANNABINOIDS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GALLAMINE TRIETHIODIDE; HETEROZYGOTE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MORPHOLINES; MUSCARINIC AGONISTS; NAPHTHALENES; NEURAL INHIBITION; NICOTINIC ANTAGONISTS; OXOTREMORINE; PATCH-CLAMP TECHNIQUES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 2942538498     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-816X.2004.03384.x     Document Type: Article

References (51)

1. 2+ signal transduction. J. Biol. Chem., 267, 13361-13368.
2. Aramori, I. & Nakanishi, S. (1992) Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron, 8, 757-765.
3. Behrends, J.C. & Ten Bruggencate, G. (1993) Cholinergic modulation of synaptic inhibition in the guinea pig hippocampus in vitro: excitation of GABAergic interneurons and inhibition of GABA-release. J. Neurophysiol., 69, 626-629.
4. Bellingham, M.C. & Berger, A.J. (1996) Presynaptic depression of excitatory synaptic inputs to rat hypoglossal motoneurons by muscarinic M2 receptors. J. Neurophysiol., 76, 3758-3770.
5. Caulfield, M.P. (1993) Muscarinic receptors - characterization, coupling and function. Pharmacol. Ther., 58, 319-379.
6. Caulfield, M.P. & Birdsall, N.J. (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev., 50, 279-290.
7. Chaudhry, F.A., Reimer, R.J., Bellocchio, E.E., Danbolt, N.C., Osen, K.K., Edwards, R.H. & Storm-Mathisen, J. (1998) The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J. Neurosci., 18, 9733-9750.
8. Chevaleyre, V. & Castillo, P.E. (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron, 38, 461-472.
9. Diana, M.A., Levenes, C., Mackie, K. & Marty, A. (2002) Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. J. Neurosci., 22, 200-208.
10. Felder, C.C., Bymaster, F.P., Ward, J. & DeLapp, N. (2000) Therapeutic opportunities for muscarinic receptors in the central nervous system. J. Med. Chem., 43, 4333-4353.
11. Hajos, N., Papp, E.C., Acsady, L., Levey, A.I. & Freund, T.F. (1998) Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience, 82, 355-376.
12. Howlett, A.C., Barth, F., Bonner, T.I., Cabrai, G., Casellas, P., Devane, W.A., Felder, C.C., Herkenham, M., Mackie, K., Martin, B.R., Mechoulam, R. & Pertwee, R.G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
13. 2+ mobilization in cultured rat hippocampal neurones. J. Physiol. (Lond.), 511, 747-759.
14. Kano, M., Ohno-Shosaku, T. & Maejima, T. (2002) Retrograde signaling at central synapses via endogenous cannabinoids. Mol. Psychiatry, 7, 234-235.
15. Karasawa, H., Taketo, M.M. & Matsui, M. (2003) Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4. Eur. J. Pharmacol., 468, 15-19.
16. Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E.S., Mackie, K. & Freund, T.F. (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci., 19, 4544-4558.
17. Kim, J., Isokawa, M., Ledent, C. & Alger, B.E. (2002) Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci., 22, 10182-10191.
18. Kimura, F. (2000) Cholinergic modulation of cortical function: a hypothetical role in shifting the dynamics in cortical network. Neurosci. Res., 38, 19-26.
19. Kreitzer, A.C. & Regehr, W.G. (2001a) Cerebellar depolarization- induced suppression of inhibition is mediated by endogenous cannabinoids. J. Neurosci., 21, RC174.
20. Kreitzer, A.C. & Regehr, W.G. (2001b) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron, 29, 717-727.
21. Kreitzer, A.C. & Regehr, W.G. (2002) Retrograde signaling by endocannabinoids. Curr. Opin. Neurobiol., 12, 324-330.
22. Levey, A.I., Edmunds, S.M., Koliatsos, V., Wiley, R.G. & Heilman, C.J. (1995) Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J. Neurosci., 15, 4077-4092.
23. Ma, X.H., Zhong, P., Gu, Z., Feng, J. & Yan, Z. (2003) Muscarinic potentiation of GABA(A) receptor currents is gated by insulin signaling in the prefrontal cortex. J. Neurosci., 23, 1159-1168.
24. Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A. & Kano, M. (2001a) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron, 31, 463-475.
25. Maejima, T., Ohno-Shosaku, T. & Kano, M. (2001b) Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals. Neurosci. Res., 40, 205-210.
26. Manuel, N.A. & Davies, C.H. (1998) Pharmacological modulation of GABA(A) receptor-mediated postsynaptic potentials in the CA1 region of the rat hippocampus. Br. J. Pharmacol., 125, 1529-1542.
27. Matsui, M., Motomura, D., Fujikawa, T., Jiang, J., Takahashi, S., Manabe, T. & Taketo, M.M. (2002) Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J. Neurosci., 22, 10627-10632,
28. Matsui, M., Motomura, D., Karasawa, H., Fujikawa, T., Jiang, J., Komiya, Y., Takahashi, S. & Taketo, M.M. (2000) Multiple functional defects in peripheral autonomie organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc. Natl Acad. Sci. USA, 97, 9579-9584.
29. Mechoulam, R., Fride, E. & Di Marzo, V. (1998) Endocannabinoids. Eur. J. Pharmacol., 359, 1-18.
30. Miyazaki, T., Fukaya, M., Shimizu, H. & Watanabe, M. (2003) Subtype switching of vesicular glutamate transporters at parallel fibre-Purkinje cell synapses in developing mouse cerebellum. Eur. J. Neurosci., 17, 2563-2572.
31. Nicoll, R.A. (1985) The septo-hippocampal projection: a model cholinergic pathway. TINS, 8, 533-536.
32. Nicoll, R.A., Malenka, R.C. & Kauer, J.A. (1990) Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol. Rev., 70, 513-565.
33. Ohno-Shosaku, T., Maejima, T. & Kano, M. (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron, 29, 729-738.
34. Ohno-Shosaku, T., Matsui, M., Fukudome, Y., Shosaku, J., Tsubokawa, H., Taketo, M.M., Manabe, T. & Kano, M. (2003) Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur. J. Neurosci., 18, 109-116.
35. Ohno-Shosaku, T., Shosaku, J., Tsubokawa, H. & Kano, M. (2002a) Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur. J. Neurosci., 15, 953-961.
36. Ohno-Shosaku, T., Tsubokawa, H., Mizushima, I., Yoneda, N., Zimmer, A. & Kano, M. (2002b) Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci., 22, 3864-3872.
37. Pettit, D.A., Harrison, M.P., Olson, J.M., Spencer, R.F. & Cabral, G.A. (1998) Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J. Neurosci. Res., 51, 391-402.
38. Pitler, T.A. & Alger, B.E. (1992) Cholinergic excitation of GABAergic interneurons in the rat hippocampal slice. J. Physiol. (Lond.), 450, 127-142.
39. Rouse, S.T., Edmunds, S.M., Yi, H., Gilmor, M.L. & Levey, A.I. (2000) Localization of M(2) muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus. Neurosci. Lett., 284, 182-186.
40. Rouse, S.T., Marino, M.J., Potter, L.T., Conn, P.J. & Levey, A.I. (1999) Muscarinic receptor subtypes involved in hippocampal circuits. Life Sci., 64, 501-509.
41. Sakai, K., Shimizu, H., Koike, T., Furuya, S. & Watanabe, M. (2003) Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/ storing glial cells in the mouse brain with transient expression in developing capillaries. J. Neurosci., 23, 550-560.
42. Shen, K.Z. & Johnson, S.W. (2000) Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J. Physiol. (Lond.), 525, 331-341.
43. Sugita, S., Uchimura, N., Jiang, Z.G. & North, R.A. (1991) Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain. Proc. Natl Acad. Sci. USA, 88, 2608-2611.
44. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K. & Walker, J.M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393-411.
45. Tsou, K., Mackie, K., Sanudo-Pena, M.C. & Walker, J.M. (1999) Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience, 93, 969-975.
46. Vilaro, M.T., Mengod, G., Palacios, G. & Palacios, J.M. (1993) Receptor distribution in the human and animal hippocampus: focus on muscarinic acetylcholine receptors. Hippocampus, 3, 149-156.
47. Vogt, K.E. & Regehr, W.G. (2001) Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus. J. Neurosci., 21, 75-83.
48. Wess, J. (1996) Molecular biology of muscarinic acetylcholine receptors. Crit. Rev. Neurobiol., 10, 69-99.
49. Wilson, R.I. & Nicoll, R.A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature, 410, 588-592.
50. Wilson, R.I. & Nicoll, R.A. (2002) Endocannabinoid signaling in the brain. Science, 296, 678-682.
51. Yoshida, T., Hashimoto, K., Zimmer, A., Maejima, T., Araishi, K. & Kano, M. (2002) The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J. Neurosci., 22, 1690-1697.